Cargando…

AB90. Contralateral upper tract urothelial carcinoma after nephroureterectomy: the predictive role of methylation status

BACKGROUND: Aberrant methylation of cytosine-guanine dinucleotide (CpG) islands is one of the most common epigenetic modifications involved in the development of urothelial carcinoma. However, it is unknown that the predictive role of methylation to contralateral new upper tract urothelial carcinoma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Lei, Xiong, Gengyan, Fang, Dong, Li, Xuesong, He, Zhisong, Zhou, Liqun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2014
Materias:	Abstract Publication Urology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708366/ http://dx.doi.org/10.3978/j.issn.2223-4683.2014.s90

Ejemplares similares

AB87. Evaluating the impact of preoperative anemia on the prognosis of upper tract urothelial carcinoma following radical nephroureterectomy
por: Xing, Yunchao, et al.
Publicado: (2014)

AB91. Risk factors and treatment outcomes of new contralateral upper urinary urothelial carcinoma after nephroureterectomy: the experiences of a large Chinese center
por: Fang, Dong, et al.
Publicado: (2014)

Contralateral upper tract urothelial carcinoma after nephroureterectomy: the predictive role of DNA methylation
por: Zhang, Lei, et al.
Publicado: (2015)

AB133. Predictive factors for worse pathological outcomes of upper tract urothelial carcinoma: experience from a nationwide high volume center of China
por: Xiong, Gengyan, et al.
Publicado: (2014)

AB93. Prognostic and predictive value of epigenetic biomarkers in upper tract urothelial carcinoma: a large-scale multi-gene promoter methylation analysis
por: Xiong, Gengyan, et al.
Publicado: (2014)

AB92. Prevalence and factors associated with baseline chronic kidney disease in China: a 10-year study of 785 upper urinary tract urothelial carcinoma patients
por: Xiong, Gengyan, et al.
Publicado: (2014)

AB121. The prognostic impact of squamous and glandular differentiation for upper tract urothelial carcinoma patients after radical nephroureterectomy
por: Tang, Qi, et al.
Publicado: (2015)

Risk Factors for Unfavorable Pathological Types of Intravesical Recurrence in Patients With Upper Urinary Tract Urothelial Carcinoma Following Radical Nephroureterectomy
por: Zhu, Jun, et al.
Publicado: (2022)

Nomogram Predicting Renal Insufficiency after Nephroureterectomy for Upper Tract Urothelial Carcinoma in the Chinese Population: Exclusion of Ineligible Candidates for Adjuvant Chemotherapy
por: Fang, Dong, et al.
Publicado: (2014)

The Influence of Tumor Size on Oncologic Outcomes for Patients with Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy
por: Su, Xiaohong, et al.
Publicado: (2016)

Impact of aristolochic acid exposure on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy
por: Zhong, Wenlong, et al.
Publicado: (2017)

Comparison between completely and traditionally retroperitoneoscopic nephroureterectomy for upper tract urothelial cancer
por: Yao, Lin, et al.
Publicado: (2016)

AB162. Prognostic and predictive value of epigenetic biomarkers and clinical factors in upper tract urothelial carcinoma
por: Xiong, Gengyan, et al.
Publicado: (2015)

High expression of KPNA2 defines poor prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy
por: Shi, Bentao, et al.
Publicado: (2015)

Nephroureterectomy of Right-to-Left Crossed Fused Renal Ectopia with Urothelial Carcinoma
por: Hearn, Jason, et al.
Publicado: (2020)

AB89. Transperitoneal subcostal access for urologic laparoscopy: experience of a large Chinese center
por: Zhang, Lei, et al.
Publicado: (2014)

AB88. Natural history of renal cell carcinoma: an immunohistochemical analysis of growth rate in patients with delayed treatment
por: Zhang, Lei, et al.
Publicado: (2014)

Combination of pembrolizumab and BCG treatment after endoscopic ablation of high-risk superficial upper urinary tract urothelial carcinoma in patients not candidates for radical nephroureterectomy: protocol for phase-II study
por: Jamil, Marcus L, et al.
Publicado: (2019)

Pattern and risk factors of local recurrence after nephroureterectomy for upper tract urothelial carcinoma
por: Li, Xiaoying, et al.
Publicado: (2020)

Role of lymph node dissection in the management of upper tract urothelial carcinomas: a meta-analysis
por: Guo, Runqi, et al.
Publicado: (2018)

AB063. Comparisons of prognosis between urothelial carcinoma of the upper urinary tract and bladder with pT3-4 diseases
por: Su, Xiaohong, et al.
Publicado: (2016)

Laparoscopic nephroureterectomy for upper tract urothelial carcinoma – Update
por: Lin, Victor C., et al.
Publicado: (2016)

Prognostic Factors for Contralateral Recurrence of Upper Tract Urothelial Carcinoma after Nephroureterectomy: A Large Multiregional Study
por: Chien, Tsu-Ming, et al.
Publicado: (2021)

AB064. Diagnostic ureteroscopy for upper tract urothelial carcinoma is independently associated with intravesical recurrence after radical nephroureterectomy
por: Liu, Pei, et al.
Publicado: (2016)

Surgical techniques and oncological outcomes of pure transperitoneal laparoscopic radical nephroureterectomy for upper urinary tract urothelial carcinoma
por: Yuan, Changwei, et al.
Publicado: (2023)

Competing-risks nomogram for predicting cancer-specific death in upper tract urothelial carcinoma: a population-based analysis
por: Li, Chengzhuo, et al.
Publicado: (2021)

Diagnostic Ureteroscopy in CT Urography-Diagnosed Upper Tract Urothelial Carcinoma: Delay in Definitive Treatment and Increased Intravesical Recurrence
por: SHSM, Hadi, et al.
Publicado: (2021)

Fate of residual ureteral stump in patients undergoing robot-assisted radical nephroureterectomy for high-risk upper tract urothelial carcinoma
por: Pathak, Ram A., et al.
Publicado: (2020)

The role of lymphadenectomy at the time of radical nephroureterectomy for upper tract urothelial carcinoma
por: Goltzman, Michael E., et al.
Publicado: (2020)

AB94. An easy model for prediction of human renal clear cell carcinoma—curve fitting for 3 kidney tumors observed for over 10 years
por: Yao, Lin, et al.
Publicado: (2014)

Comparison of clinicopathologic characteristics, epigenetic biomarkers and prognosis between renal pelvic and ureteral tumors in upper tract urothelial carcinoma
por: Fang, Dong, et al.
Publicado: (2018)

The Evolution of Clinicopathological Diagnostic Features of Upper Tract Urothelial Carcinoma in China: A Summary of 2561 Cases in the Last 20 Years
por: Xu, Chunru, et al.
Publicado: (2022)

Effectiveness and Safety of Thulium Fiber Laser in the Conservative Management of Patients with Upper Tract Urothelial Carcinoma
por: Proietti, Silvia, et al.
Publicado: (2022)

Radiofrequency-Treated Recurrence of Urothelial Carcinoma of the Upper Urinary Tract After Nephroureterectomy
por: Molina, Roberto, et al.
Publicado: (2014)

Comparison of Radical Nephroureterectomy and Partial Ureterectomy for the Treatment of Upper Tract Urothelial Carcinoma
por: Zhang, Jianzhong, et al.
Publicado: (2018)

Aristolochic acid containing herbs induce gender-related oncological differences in upper tract urothelial carcinoma patients
por: Xiong, Gengyan, et al.
Publicado: (2018)

Systematic review and meta-analysis of completely retroperitoneoscopic nephroureterectomy versus traditional retroperitoneoscopic nephroureterectomy in upper tract urothelial carcinoma
por: Zhao, Yan, et al.
Publicado: (2023)

AB113. Comparisons of prognosis between urothelial carcinoma of the upper urinary tract and bladder with pT3-4 diseases
por: Su, Xiaohong, et al.
Publicado: (2015)

Patient‐Derived Upper Tract Urothelial Carcinoma Organoids as a Platform for Drug Screening
por: Li, Zhichao, et al.
Publicado: (2021)

Prognostic significance of sarcopenia in upper tract urothelial carcinoma patients treated with radical nephroureterectomy
por: Fukushima, Hiroshi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ugdlv158msrpm5qrilck17bv37